130 related articles for article (PubMed ID: 33188849)
1. Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia.
Wang C; Li L; Li M; Shen X; Liu Y; Wang S
Exp Cell Res; 2021 Jan; 398(1):112371. PubMed ID: 33188849
[TBL] [Abstract][Full Text] [Related]
2. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
Heltemes-Harris LM; Willette MJ; Ramsey LB; Qiu YH; Neeley ES; Zhang N; Thomas DA; Koeuth T; Baechler EC; Kornblau SM; Farrar MA
J Exp Med; 2011 Jun; 208(6):1135-49. PubMed ID: 21606506
[TBL] [Abstract][Full Text] [Related]
3. Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins.
Gupta R; Li W; Yan XJ; Barrientos J; Kolitz JE; Allen SL; Rai K; Chiorazzi N; Mongini PKA
J Immunol; 2019 May; 202(10):2924-2944. PubMed ID: 30988120
[TBL] [Abstract][Full Text] [Related]
4. Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development.
Timblin GA; Schlissel MS
J Immunol; 2013 Nov; 191(9):4676-87. PubMed ID: 24068669
[TBL] [Abstract][Full Text] [Related]
5. CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.
Gordiienko I; Shlapatska L; Kholodniuk VM; Kovalevska L; Ivanivskaya TS; Sidorenko SP
Exp Oncol; 2017 Dec; 39(4):291-298. PubMed ID: 29284783
[TBL] [Abstract][Full Text] [Related]
6. STAT3-induced SMYD3 transcription enhances chronic lymphocytic leukemia cell growth in vitro and in vivo.
Lin F; Wu D; Fang D; Chen Y; Zhou H; Ou C
Inflamm Res; 2019 Sep; 68(9):739-749. PubMed ID: 31218443
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.
Welsh SJ; Churchman ML; Togni M; Mullighan CG; Hagman J
Leukemia; 2018 Jan; 32(1):38-48. PubMed ID: 28555080
[TBL] [Abstract][Full Text] [Related]
8. GIFT4 fusokine converts leukemic B cells into immune helper cells.
Deng J; Pennati A; Cohen JB; Wu Y; Ng S; Wu JH; Flowers CR; Galipeau J
J Transl Med; 2016 Apr; 14(1):106. PubMed ID: 27118475
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells.
de Totero D; Meazza R; Zupo S; Cutrona G; Matis S; Colombo M; Balleari E; Pierri I; Fabbi M; Capaia M; Azzarone B; Gobbi M; Ferrarini M; Ferrini S
Blood; 2006 May; 107(9):3708-15. PubMed ID: 16391014
[TBL] [Abstract][Full Text] [Related]
10. In chronic lymphocytic leukemia, activation of the thrombopoietin receptor promotes T-cell inhibitory properties, contributing to immunosuppression.
Ringelstein-Harlev S; Fanadka M; Horowitz NA; Bettman NP; Katz T
Eur J Haematol; 2023 Apr; 110(4):371-378. PubMed ID: 36478591
[TBL] [Abstract][Full Text] [Related]
11. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
[TBL] [Abstract][Full Text] [Related]
12. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of CacyBP/SIP in chronic lymphocytic leukemia cell balances of cell proliferation with apoptosis.
Fu C; Wan Y; Shi H; Gong Y; Wu Q; Yao Y; Niu M; Li Z; Xu K
J Cancer Res Clin Oncol; 2016 Apr; 142(4):741-8. PubMed ID: 26603518
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.
Heckl D; Schwarzer A; Haemmerle R; Steinemann D; Rudolph C; Skawran B; Knoess S; Krause J; Li Z; Schlegelberger B; Baum C; Modlich U
Mol Ther; 2012 Jun; 20(6):1187-95. PubMed ID: 22472950
[TBL] [Abstract][Full Text] [Related]
15. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia.
Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C
Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812
[TBL] [Abstract][Full Text] [Related]
16. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5.
Roessler S; Györy I; Imhof S; Spivakov M; Williams RR; Busslinger M; Fisher AG; Grosschedl R
Mol Cell Biol; 2007 Jan; 27(2):579-94. PubMed ID: 17101802
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
18. STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1.
Battle TE; Frank DA
Blood; 2003 Oct; 102(8):3016-24. PubMed ID: 12855573
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival.
Pal Singh S; de Bruijn MJW; Velaso Gago da Graça C; Corneth OBJ; Rip J; Stadhouders R; Meijers RWJ; Schurmans S; Kerr WG; Ter Burg J; Eldering E; Langerak AW; Pillai SY; Hendriks RW
J Immunol; 2020 Jan; 204(2):360-374. PubMed ID: 31836657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
